α-Synuclein overexpression enhances manganese-induced neurotoxicity through the NF-κB-mediated pathway

References

• Auluck PK, Chan HY, Trojanowski JQ, Lee VM, Bonini NM. 2002. Chaperone suppression of α-synuclein toxicity in a Drosophila model for Parkinson’s disease. Science 295:865–868.
   PubMed Web of Science ®Google Scholar
• Baichwal VR, Baeuerie PA. 1997. Activate NF-κB or die? Curr Biol 7:R94–R96
   PubMed Web of Science ®Google Scholar
• Calabrese V, Ravagna A, Colombrita C, Scapagnini G, Guagliano E, Calvani M, Butterfield DA, Giuffrida Stella AM. 2005. Acetylcarnitine induces heme oxygenase in rat astrocytes and protects against oxidative stress: involvement of the transcription factor Nrf2. J Neurosci Res 79:509–521.
   PubMed Web of Science ®Google Scholar
• Chae HJ, Kim SC, Han KS, Chae SW, An NH, Kim HM, Kim HH, Lee ZH, Kim HR. 2001. Hypoxia induces apoptosis by caspase activation accompanying cytochrome C release from mitochondria in MC3T3E1 osteoblasts. p38 MAPK is related in hypoxia-induced apoptosis. Immunopharmacol Immunotoxicol 23:133–152.
   PubMed Web of Science ®Google Scholar
• Chang JY, Liu LZ. 1999. Manganese potentiates nitric oxide production by microglia. Brain Res Mol Brain Res 68:22–28.
   PubMedGoogle Scholar
• Choi-Lundberg DL, Lin Q, Chang YN, Chiang YL, Hay CM, Mohajeri H, Davidson BL, Bohn MC. 1997. Dopaminergic neurons protected from degeneration by GDNF gene therapy. Science 275:838–841.
   PubMed Web of Science ®Google Scholar
• Cookson MR. 2005. The biochemistry of Parkinson’s disease. Annu Rev Biochem 74:29–52.
   PubMed Web of Science ®Google Scholar
• Cookson MR. 2009. α-Synuclein and neuronal cell death. Mol Neurodegener 4:9.
   PubMed Web of Science ®Google Scholar
• Crossgrove J, Zheng W. 2004. Manganese toxicity upon overexposure. NMR Biomed 17:544–553.
   PubMed Web of Science ®Google Scholar
• De Zutter GS, Davis RJ. 2001. Pro-apoptotic gene expression mediated by the p38 mitogen-activated protein kinase signal transduction pathway. Proc Natl Acad Sci USA 98:6168–6173.
   PubMed Web of Science ®Google Scholar
• Dawson TM, Dawson VL. 2003. Molecular pathways of neurodegeneration in Parkinson’s disease. Science 302:819–822.
   PubMed Web of Science ®Google Scholar
• Dobson AW, Erikson KM, Aschner M. 2004. Manganese neurotoxicity. Ann N Y Acad Sci 1012:115–128.
   PubMed Web of Science ®Google Scholar
• Di Monte DA, Lavasani M, Manning-Bog AB. 2002. Environmental factors in Parkinson’s disease. Neurotoxicology 23:487–502.
   PubMed Web of Science ®Google Scholar
• Dauer W, Kholodilov N, Vila M, Trillat AC, Goodchild R, Larsen KE, Staal R, Tieu K, Schmitz Y, Yuan CA, Rocha M, Jackson-Lewis V, Hersch S, Sulzer D, Przedborski S, Burke R, Hen R. 2002. Resistance of α -synuclein null mice to the parkinsonian neurotoxin MPTP. Proc Natl Acad Sci USA 99:14524–14529.
   PubMed Web of Science ®Google Scholar
• El Mchichi B, Hadji A, Vazquez A, Leca G. 2007. p38 MAPK and MSK1 mediate caspase-8 activation in manganese-induced mitochondria-dependent cell death. Cell Death Differ 14:1826–1836.
   PubMed Web of Science ®Google Scholar
• Forno LS. 1996. Neuropathology of Parkinson’s disease. J Neuropathol Exp Neurol 55:259–272.
   PubMed Web of Science ®Google Scholar
• Feany MB, Bender WW. 2000. A Drosophila model of Parkinson’s disease. Nature 404:394–398.
   PubMed Web of Science ®Google Scholar
• Gitler AD, Chesi A, Geddie ML, Strathearn KE, Hamamichi S, Hill KJ, Caldwell KA, Caldwell GA, Cooper AA, Rochet JC, Lindquist S. 2009. α-Synuclein is part of a diverse and highly conserved interaction network that includes PARK9 and manganese toxicity. Nat Genet 41:308–315.
   PubMed Web of Science ®Google Scholar
• Gonzalez LE, Juknat AA, Venosa AJ, Verrengia N, Kotler ML. 2008. Manganese activates the mitochondrial apoptotic pathway in rat astrocytes by modulating the expression of proteins of the Bcl-2 family. Neurochem Int 53:408–415.
   PubMed Web of Science ®Google Scholar
• Guilarte TR, Chen MK, McGlothan JL, Verina T, Wong DF, Zhou Y, Alexander M, Rohde CA, Syversen T, Decamp E, Koser AJ, Fritz S, Gonczi H, Anderson DW, Schneider JS. 2006. Nigrostriatal dopamine system dysfunction and subtle motor deficits in manganese-exposed non-human primates. Exp Neurol 202:381–390.
   PubMed Web of Science ®Google Scholar
• Halvorsen EM, Dennis J, Keeney P, Sturgill TW, Tuttle JB, Bennett JB Jr. 2002. Methylpyridinium (MPP(+))- and nerve growth factor-induced changes in pro- and anti-apoptotic signaling pathways in SH-SY5Y neuroblastoma cells. Brain Res 952:98–110.
   PubMed Web of Science ®Google Scholar
• Hancock JT, Desikan R, Neill SJ. 2001. Role of reactive oxygen species in cell signalling pathways. Biochem Soc Trans 29:345–350.
   PubMed Web of Science ®Google Scholar
• Hornykiewicz O. 1998. Biochemical aspects of Parkinson’s disease. Neurology 51:S2–S9.
   PubMed Web of Science ®Google Scholar
• Hong Z, Shi M, Chung KA, Quinn JF, Peskind ER, Galasko D, Jankovic J, Zabetian CP, Leverenz JB, Baird G, Montine TJ, Hancock AM, Hwang H, Pan C, Bradner J, Kang UJ, Jensen PH, Zhang J. 2010. DJ-1 and α-synuclein in human cerebrospinal fluid as biomarkers of Parkinson’s disease. Brain 133:713–726.
   PubMed Web of Science ®Google Scholar
• Hashimoto M, Hsu LJ, Rockenstein E, Takenouchi T, Mallory M, Masliah E. 2002. α-Synuclein protects against oxidative stress via inactivation of the c-Jun N-terminal kinase stress-signaling pathway in neuronal cells. J Biol Chem 277:11465–11472.
   PubMed Web of Science ®Google Scholar
• Hensley K, Robinson KA, Gabbita SP, Salsman S, Floyd RA. 2000. Reactive oxygen species, cell signaling, and cell injury. Free Radic Biol Med 28:1456–1462.
   PubMed Web of Science ®Google Scholar
• Hornykiewicz O. 1998. Biochemical aspects of Parkinson’s disease. Neurology Suppl 2:S2–S9.
   Google Scholar
• Hsu LJ, Sagara Y, Arroyo A, Rockenstein E, Sisk A, Mallory M, Wong J, Takenouchi T, Hashimoto M, Masliah E. 2000. α-synuclein promotes mitochondrial deficit and oxidative stress. Am J Pathol 157:401–410.
   PubMed Web of Science ®Google Scholar
• Iregren A. 1999. Manganese neurotoxicity in industrial exposures: proof of effects, critical exposure level, and sensitive tests. Neurotoxicology 20:315–323.
   PubMed Web of Science ®Google Scholar
• Karin M. 1999. How NF-κB is activated: the role of the IκB kinase (IKK) complex. Oncogene 18:6867–6874.
   PubMed Web of Science ®Google Scholar
• Le W, Rowe D, Xie W, Ortiz I, He Y, Appel SH. 2001. Microglial activation and dopaminergic cell injury: an in vitro model relevant to Parkinson’s disease. J Neurosci 21:8447–8455.
   PubMed Web of Science ®Google Scholar
• Li Y, Sun L, Cai T, Zhang Y, Lv S, Wang Y, Ye L. 2010. α-Synuclein overexpression during manganese-induced apoptosis in SH-SY5Y neuroblastoma cells. Brain Res Bull 81:428–433.
   PubMed Web of Science ®Google Scholar
• Masliah E, Rockenstein E, Veinbergs I, Mallory M, Hashimoto M, Takeda A, Sagara Y, Sisk A, Mucke L. 2000. Dopaminergic loss and inclusion body formation in α-synuclein mice: implications for neurodegenerative disorders. Science 287:1265–1269.
   PubMed Web of Science ®Google Scholar
• Matsuoka Y, Vila M, Lincoln S, McCormack A, Picciano M, LaFrancois J, Yu X, Dickson D, Langston WJ, McGowan E, Farrer M, Hardy J, Duff K, Przedborski S, Di Monte DA. 2001. Lack of nigral pathology in transgenic mice expressing human α-synuclein driven by the tyrosine hydroxylase promoter. Neurobiol Dis 8:535–539.
   PubMed Web of Science ®Google Scholar
• Manning-Bog AB, McCormack AL, Li J, Uversky VN, Fink AL, Di Monte DA. 2002. The herbicide paraquat causes up-regulation and aggregation of α-synuclein in mice: paraquat and α-synuclein. J Biol Chem 277:1641–1644.
   PubMed Web of Science ®Google Scholar
• Mergler D, Baldwin M. 1997. Early manifestations of manganese neurotoxicity in humans: an update. Environ Res 73:92–100.
   PubMed Web of Science ®Google Scholar
• Olanow CW. 2004. Manganese-induced parkinsonism and Parkinson’s disease. Ann N Y Acad Sci 1012:209–223.
   PubMed Web of Science ®Google Scholar
• Ostrerova-Golts N, Petrucelli L, Hardy J, Lee JM, Farer M, Wolozin B. 2000. The A53T α-synuclein mutation increases iron-dependent aggregation and toxicity. J Neurosci 20:6048–6054.
   PubMed Web of Science ®Google Scholar
• Perl DP, Olanow CW. 2007. The neuropathology of manganese-induced Parkinsonism. J Neuropathol Exp Neurol 66:675–682.
   PubMed Web of Science ®Google Scholar
• Ponzoni S, Gaziri LC, Britto LR, Barreto WJ, Blum D. 2002. Clearance of manganese from the rat substantia nigra following intra-nigral microinjections. Neurosci Lett 328:170–174.
   PubMed Web of Science ®Google Scholar
• Prabhakaran K, Ghosh D, Chapman GD, Gunasekar PG. 2008. Molecular mechanism of manganese exposure-induced dopaminergic toxicity. Brain Res Bull 76:361–367.
   PubMed Web of Science ®Google Scholar
• Prabhakaran K, Chapman GD, Gunasekar PG. 2009. BNIP3 up-regulation and mitochondrial dysfunction in manganese-induced neurotoxicity. Neurotoxicology 30:414–422.
   PubMed Web of Science ®Google Scholar
• Prasad JE, Kumar B, Andreatta C, Nahreini P, Hanson AJ, Yan XD, Prasad KN. 2004. Overexpression of α-synuclein decreased viability and enhanced sensitivity to prostaglandin E(2), hydrogen peroxide, and a nitric oxide donor in differentiated neuroblastoma cells. J Neurosci Res 76:415–422.
   PubMed Web of Science ®Google Scholar
• Pulido MD, Parrish AR. 2003. Metal-induced apoptosis: mechanisms. Mutat Res 533:227–241.
   PubMed Web of Science ®Google Scholar
• Roth JA, Garrick MD. 2003. Iron interactions and other biological reactions mediating the physiological and toxic actions of manganese. Biochem Pharmacol 66:1–13.
   PubMed Web of Science ®Google Scholar
• Ruan Q, Harrington AJ, Caldwell KA, Caldwell GA, Standaert DG. 2010. VPS41, a protein involved in lysosomal trafficking, is protective in Caenorhabditis elegans and mammalian cellular models of Parkinson’s disease. Neurobiol Dis 37:330–338.
   PubMed Web of Science ®Google Scholar
• Saha AR, Ninkina NN, Hanger DP, Anderton BH, Davies AM, Buchman VL. 2000. Induction of neuronal death by α-synuclein. Eur J Neurosci 12:3073–3077.
   PubMed Web of Science ®Google Scholar
• Shavali S, Combs CK, Ebadi M. 2006. Reactive macrophages increase oxidative stress and α-synuclein nitration during death of dopaminergic neuronal cells in co-culture: relevance to Parkinson’s disease. Neurochem Res 31:85–94.
   PubMed Web of Science ®Google Scholar
• Shuto T, Xu H, Wang B, Han J, Kai H, Gu XX, Murphy TF, Lim DJ, Li JD. 2001. Activation of NF-κB by nontypeable Hemophilus influenzae is mediated by toll-like receptor 2-TAK1-dependent NIK-IKK α/β-IκBα and MKK3/6-p38 MAP kinase signaling pathways in epithelial cells. Proc Natl Acad Sci USA 98:8774–8779.
   PubMed Web of Science ®Google Scholar
• Singleton AB, Farrer M, Johnson J, Singleton A, Hague S, Kachergus J, Hulihan M, Peuralinna T, Dutra A, Nussbaum R, Lincoln S, Crawley A, Hanson M, Maraganore D, Adler C, Cookson MR, Muenter M, Baptista M, Miller D, Blancato J, Hardy J, Gwinn-Hardy K. 2003. α-Synuclein locus triplication causes Parkinson’s disease. Science 302:841.
   PubMed Web of Science ®Google Scholar
• Spillantini MG, Goedert M. 2000. The α-synucleinopathies: Parkinson’s disease, dementia with Lewy bodies, and multiple system atrophy. Ann N Y Acad Sci 920:16–27.
   PubMed Web of Science ®Google Scholar
• Tong M, Dong M, de la Monte SM. 2009. Brain insulin-like growth factor and neurotrophin resistance in Parkinson’s disease and dementia with Lewy bodies: potential role of manganese neurotoxicity. J Alzheimers Dis 16:585–599.
   PubMed Web of Science ®Google Scholar
• U.S. Army Center for Health Promotion and Preventive Medicine. 2008. Micro-particulate surveillance reports.
   Google Scholar
• Uversky VN, Li J, Fink AL. 2001. Pesticides directly accelerate the rate of α-synuclein fibril formation: a possible factor in Parkinson’s disease. FEBS Lett 500:105–108.
   PubMed Web of Science ®Google Scholar
• Wang CY, Guttridge DC, Mayo MW, Baldwin AS Jr. 1999. NF-κB induces expression of the Bcl-2 homologue A1/Bfl-1 to preferentially suppress chemotherapy-induced apoptosis. Mol Cell Biol 19:5923–5929.
   PubMed Web of Science ®Google Scholar
• Whitmarsh AJ, Davis RJ. 1996. Transcription factor AP-1 regulation by mitogen-activated protein kinase signal transduction pathways. J Mol Med 74:589–607.
   PubMed Web of Science ®Google Scholar
• Yamagishi S, Yamada M, Ishikawa Y, Matsumoto T, Ikeuchi T, Hatanaka H. 2001. p38 mitogen-activated protein kinase regulates low potassium-induced c-Jun phosphorylation and apoptosis in cultured cerebellar granule neurons. J Biol Chem 276:5129–5133.
   PubMed Web of Science ®Google Scholar
• Zhou W, Hurlbert MS, Schaack J, Prasad KN, Freed CR. 2000. Overexpression of human α-synuclein causes dopamine neuron death in rat primary culture and immortalized mesencephalon-derived cells. Brain Res 866:33–43.
   PubMed Web of Science ®Google Scholar